Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib

BACKGROUND AND AIMS: Vascular endothelial growth factor‐directed therapies play a significant role in patients with metastatic renal cell carcinoma (mRCC). Biomarkers for predicting treatment efficacy and resistance are required to develop personalized medicine. We evaluated multiple serum cytokine...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Health Sci Rep
Asıl Yazarlar: Honma, Naoko, Inoue, Takamitsu, Tsuchiya, Norihiko, Koizumi, Atsushi, Yamamoto, Ryohei, Nara, Taketoshi, Kanda, Sohei, Huang, Mingguo, Numakura, Kazuyuki, Saito, Mitsuru, Narita, Shintaro, Satoh, Shigeru, Habuchi, Tomonori
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7559632/
https://ncbi.nlm.nih.gov/pubmed/33088925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hsr2.197
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller